Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Carisma Therapeutics Inc 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 USA

https://carismatx.com Employees: 46 P: 267-491-6422

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,611
Enterprise Value, $K -16,299
Shares Outstanding, K 41,845
Float, K 38,958
% Float 93.10%
Short Interest, K 290
Short Float 0.69%
Days to Cover 1.00
Short Volume Ratio 0.29
% of Insider Shareholders 6.90%
% of Institutional Shareholders 44.27%

Financials:

Annual Sales, $ 19,630 K
Annual Net Income, $ -60,480 K
Last Quarter Sales, $ 45,250 K
Last Quarter Net Income, $ 44,720 K
EBIT, $ 10,840 K
EBITDA, $ 14,190 K

Growth:

1-Year Return -91.89%
3-Year Return -99.68%
5-Year Return -99.94%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.07 on 11/12/25
Next Earnings Date 02/11/26
Earnings Per Share ttm 0.73
EPS Growth vs. Prev Qtr 991.67%
EPS Growth vs. Prev Year 445.16%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 03/08/23

CARM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.89%
Return-on-Assets % 86.30%
Profit Margin % -308.10%
Debt/Equity 0.00
Price/Sales 0.60
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -1.73
60-Month Beta 1.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar